- 24 h
- 7 Tage
- 14 Tage
- 6 Monate
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 22:18 | Precigen GAAP EPS of -$0.02 beats by $0.02, revenue of $23.25M beats by $2.45M | - | Seeking Alpha | ||
| 22:18 | Insight Molecular Diagnostics Inc. GAAP EPS of -$0.12 beats by $0.14, revenue of $0.32M beats by $0.09M | - | Seeking Alpha | ||
| 22:17 | Praxis Precision Medicines, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 22:17 | GRI Bio, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 22:16 | Aptevo Therapeutics Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 22:14 | MACROGENICS INC - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 22:14 | SPRUCE BIOSCIENCES, INC. - S-8, Securities to be offered to employees in employee benefit plans | 2 | SEC Filings | ||
| 22:14 | Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the First Quarter 2026 | 66 | ACCESS Newswire | - Dermata announced their Tome Skincare brand for direct-to-consumer ("DTC") skincare products -- Dermata plans to launch its first DTC product, the Tome Foundational Treatment, a once-weekly mask to... ► Artikel lesen | |
| 22:12 | Inovio Pharmaceuticals GAAP EPS of -$0.28 beats by $0.07 | 1 | Seeking Alpha | ||
| 22:12 | Oruka Therapeutics GAAP EPS of -$0.48 beats by $0.07 | 3 | Seeking Alpha | ||
| 22:12 | Dyadic International, Inc.: Dyadic Announces First Quarter 2026 Financial Results and Highlights Recent Company Progress | 1 | GlobeNewswire (USA) | ||
| 22:12 | vTv Therapeutics GAAP EPS of $1.65 beats by $1.21, revenue of $36.84M beats by $26.84M | 1 | Seeking Alpha | ||
| 22:12 | Tango Therapeutics, Inc.: Tango Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Highlights | 1 | GlobeNewswire (USA) | ||
| 22:12 | Medicenna launches marketed public offering of securities | 1 | Seeking Alpha | ||
| 22:12 | Acrivon Therapeutics, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 22:12 | Acrivon Therapeutics, Inc: Acrivon Reports First Quarter 2026 Financial Results and Highlights Progress Towards Key 2026 Clinical Catalysts | 2 | GlobeNewswire (USA) | ||
| 22:11 | DYADIC INTERNATIONAL INC - 10-Q, Quarterly Report | 2 | SEC Filings | ||
| 22:11 | DYADIC INTERNATIONAL INC - 8-K, Current Report | 1 | SEC Filings | ||
| 22:11 | Equillium, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 22:10 | Earnings call transcript: Iovance Biotherapeutics verfehlt im ersten Quartal 2026 Gewinn- und Umsatzprognosen | 3 | Investing.com Deutsch |
1 2 3 4 5 Weiter >>
- 24 h
- 7 Tage
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | Aktuelle Nachrichten | |||
|---|---|---|---|---|---|---|---|
| EVOTEC | 22 | 44 | -10,63 % | EQS-News: Evotec SE: Evotec gibt Ergebnisse für das erste Quartal 2026 bekannt: Transformation gewinnt an Dynamik | EQS-News: Evotec SE
/ Schlagwort(e): Quartalsergebnis/Quartals-/Zwischenmitteilung
Evotec gibt Ergebnisse für das erste Quartal 2026 bekannt: Transformation gewinnt an Dynamik... ► Artikel lesen | ||
| VALNEVA | 7 | 5 | -1,01 % | Valneva-Aktie vor Zahlen: Was ist am 13. Mai zu erwarten? | Die Aktie von Valneva bleibt auch nach der jüngsten Kapitalspritze unter Druck. Nachdem bereits in unserem vorherigen Artikel auf die begrenzten Erholungschancen hingewiesen wurde, bestätigt die aktuelle... ► Artikel lesen | ||
| PROTALIX BIOTHERAPEUTICS | 7 | 1 | +4,69 % | Protalix BioTherapeutics, Inc.: Protalix BioTherapeutics Reports First Quarter 2026 Financial and Business Results | Company to host conference call and webcast today at 8:00 a.m. EDT
Elfabrio commercial execution continues following European Commission approval of the 2 mg/kg... ► Artikel lesen | ||
| VERRICA PHARMACEUTICALS | 7 | - | -4,09 % | Verrica Pharmaceuticals Inc.: Verrica Pharmaceuticals Reports First Quarter 2026 Financial Results | - Company reports record demand for YCANTH as dispensed applicator units grew to 15,302 in Q1 2026, up 12.1% over the previous quarter and 51.3% year-over-year, and has now exceeded 100,000 dispensed... ► Artikel lesen | ||
| BIONTECH | 6 | 13 | -1,07 % | Curevac-Gründer wirft Biontech Täuschung vor | TÜBINGEN/MAINZ (dpa-AFX) - Nach der Übernahme des Biotechunternehmens Curevac durch Biontech wirft Curevac-Gründer Ingmar Hoerr dem Konkurrenten Täuschung vor. Hintergrund sind die Schließungspläne... ► Artikel lesen | ||
| ABEONA THERAPEUTICS | 6 | 5 | -3,16 % | Abeona Therapeutics Inc.: Abeona Therapeutics Reports First Quarter 2026 Results and Provides Pipeline Update | - Three patients treated with ZEVASKYN- in Q1 2026 - - QTC network expands to six sites, with two new additions on the East Coast - - In-licensed radically novel engineered T-cell technology with... ► Artikel lesen | ||
| BEONE MEDICINES LTD ADR | 5 | 10 | 0,00 % | BeOne Medicines Ltd: BeOne Medicines gibt die Finanzergebnisse für das erste Quartal 2026 sowie aktuelle Geschäftsentwicklungen bekannt | Weltweiter Umsatz von 1,5 Milliarden US-Dollar im ersten Quartal, ein Anstieg von 35 gegenüber dem Vorjahr
Der weltweite Umsatz mit dem Kernprodukt BRUKINSA (Zanubrutinib) belief... ► Artikel lesen | ||
| IMMUNIC | 5 | 2 | +9,08 % | EQS-News: Immunic AG: Immunic, Inc. Reports First Quarter 2026 Financial Results and Provides Corporate Update | Issuer: Immunic AG
/ Key word(s): Quarter Results
Immunic, Inc. Reports First Quarter 2026 Financial Results and Provides Corporate Update
13.05.2026 / 12:30 CET/CEST
The... ► Artikel lesen | ||
| KURA ONCOLOGY | 5 | 2 | -5,83 % | Kura Oncology, Inc.: Kura Oncology Reports First Quarter 2026 Financial Results | - $5.8 million in KOMZIFTI (ziftomenib) net product revenue in first full quarter of commercialization - - Robust new patient starts and early launch dynamics, including repeat use, switching and... ► Artikel lesen | ||
| CURIS | 5 | 1 | -0,85 % | Curis, Inc.: Curis Provides First Quarter 2026 Business Update | Management to host conference call today at 4:30 p.m. ET
LEXINGTON, Mass., May 12, 2026 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused... ► Artikel lesen |
- Alle
| Unternehmen / Aktien | Aktueller Kurs | Ø Kursziel (Euro) | Potential (Euro) | kaufen | halten | verkaufen | |||
|---|---|---|---|---|---|---|---|---|---|
| BIO-GATE AG | 0,750 | 3,40 | +353 % | 1 | - | - | |||
| DARWIN AG | 7,350 | 30 | +308 % | 1 | - | - | |||
| NANOREPRO AG | 1,485 | 4,50 | +203 % | 2 | - | - | |||
| EVOTEC SE | 4,540 | 8,07 | +78 % | 7 | 3 | - | |||
| BIONTECH SE ADR | 78,95 | 118,37 | +50 % | 7 | - | - | |||
| SARTORIUS STEDIM BIOTECH SA | 162,60 | 232,14 | +43 % | 13 | 2 | - | |||
| ARGENX SE | 676,80 | 838 | +24 % | 15 | 3 | - | |||
| MODERNA INC | 43,090 | 38,28 | -11 % | - | 1 | - |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.